Clinical and histopathological tumour progression in ECL cell carcinoids (“ECLomas”)
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Aims: The aims of this study were to illustrate the malignant potential of gastric enterochromaffin‐like (ECL) cell carcinoids (ECLomas) associated with hypergastrinemia, and the gradual neoplastic progression of such tumours. In addition, we examined whether the tyramide signal amplification (TSA) technique could visualize immunohistochemical (IHC) neuroendocrine (NE) features in the dedifferentiated neoplastic ECL cells which were not detected by conventional methods. Methods: Conventional histopathological and IHC methods for visualizing ECL cells and cell proliferation were used in addition to the TSA technique. Observations: Our patient was followed for 5 years. During that period, her ECLoma displayed all the signs of classical tumour progression, ultimately with the appearance of metastases in the regional lymph nodes, the liver and the skin. The neoplastic ECL cells became progressively dedifferentiated with an increasing number of Ki‐67 immunoreactive (IR) cell nuclei. In addition, there was a substantial decrease in argyrophil and IR NE cells that could be visualized by conventional methods. By applying the TSA technique, however, the number of IR tumour cells increased considerably. Conclusions: ECLomas secondary to hypergastrinemia should be closely followed for signs of clinical and histopathological tumour progression. Such ECLomas deserve early, active, radical surgical treatment. The TSA technique is a valuable tool for visualizing the characteristic IHC features in dedifferentiated NE cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Cited by
Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial
Atkinson, W., Sheldon, T. A., Shaath, N., & Whorwell, P. J. (2004) · Gut · doi:10.1136/gut.2003.037697 · Cited by 534
Jowett, S. L., Seal, C. J., Pearce, M. S., Phillips, E., Gregory, W., Barton, J. R., & Welfare, M. R. (2004) · Gut · doi:10.1136/gut.2003.024828 · Cited by 462
Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor.
Jianu, C. S., Lange, O. J., Viset, T., Qvigstad, G., Martinsen, T. C., Fougner, R., Kleveland, P. M., Fossmark, R., Hauso, Ø., & Waldum, H. L. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.627444 · Cited by 80
Self-citationThe Enterochromaffin-like [ECL] Cell—Central in Gastric Physiology and Pathology
Waldum, H. L., Sørdal, Ø. F., & Mjønes, P. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102444 · Cited by 45
Self-citation
Metadata
- Authors
- Qvigstad, G., Falkmer, S., Westre, B., & Waldum, H. L.
- Venue
- APMIS
- Publisher
- Wiley
- Published
- 1999-03
- Volume
- 107
- Issue
- 7-12
- Pages
- 1085-1092
- ISSN
- 0903-4641 (ISSN-L)
- 1600-0463
- OpenAlex
- W2011271268
- Cited by
- 79
- References
- 1
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical and histopathological tumour progression in ECL cell carcinoids (“ECLomas”). https://app.cochat.ai/papers/10.1111/j.1699-0463.1999.tb01513.x
- The paper
- Qvigstad, G., Falkmer, S., Westre, B., & Waldum, H. L. (1999). Clinical and histopathological tumour progression in ECL cell carcinoids (“ECLomas”). APMIS. https://doi.org/10.1111/j.1699-0463.1999.tb01513.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.